Major Study Heralds New Era In Treatment Of Type 2 Diabetes
Diabetes can cause a narrowing of blood vessels between the knee and the toes causing a decrease in oxygen circulation that prevents healingMore In addition, canagliflozin , which is a sodium glucose cotransporter-2 inhibitor , showed potential renal protective effects, delaying progression of albuminuria and reducing the risk of clinically important renal composite outcomes by 40% . Patients given Invokana were 14 percent less likely to suffer a heart attack , stroke or die from heart disease than those given a placebo, according to the combined data from two studies presented at the American Diabetes Association's annual meeting .
Start the conversation, or Read more at The Oak Ridge Observer.